{"version":"1.0","type":"link","title":"Biomarker analyses to predict benefit of immune checkpoint inhibitors for EGFR-mutated non-small cell lung cancer.","author_name":"Azuma K 외","author_url":"https://prs-insight.online/author/Azuma%20K","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/97531","thumbnail_width":1200,"thumbnail_height":630}